UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000017302
Receipt No. R000020077
Official scientific title of the study Study about efficacy of Dexmedetomidine as a novel sedative agent during ESD for esophageal cancer
Date of disclosure of the study information 2015/04/28
Last modified on 2018/12/21 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Study about efficacy of Dexmedetomidine as a novel sedative agent during ESD for esophageal cancer
Title of the study (Brief title) Efficacy of Dexmedetomidine during esophageal ESD
Region
Japan

Condition
Condition Esophageal cancer (SCC)
Classification by specialty
Gastroenterology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate the efficacy of new sedation using Dexmedetomidine during ESD for esophageal cancer in prospective study
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase Phase II

Assessment
Primary outcomes The ratio of the cases with no body movement during ESD
Key secondary outcomes 1 The frequency of respiratory depression, hypotention and bradycardia
2 Patients' levels of conciousness and suffer
3 Endoscopists' satisfaction level for sedation
4 Efficacy of BIS
5 Total consumed amount of midazolam and pethidine hydrochloride

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Sadation by dexmedetomidine, midazolam and pethidine hydrochloride during esophageal ESD
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >=
Gender Male and Female
Key inclusion criteria 1 Histologically diagnosed squamous cell carcinoma by endoscopic biopsy
2 SM1 or less in tumor invasion by preoperative diagnosis
3 Located in Ut/Mt/Lt/Ae, and able to perform ESD without intubation
4 No lymph node or distant metastasis by preoperative CT
5 Age is 20-80
6 Performance status is 0-2
7 No severe organ dysfunction
8 Written informed consent are obtained
Key exclusion criteria 1 Uncontrollable hypertention
2 Uncontrollable heart disease or arrhythmia
3 Respiratory disease needed oxygen in rest
4 Unstable angina (newly occurred or worsened in these 3 weeks) or myocardial infarction within 6 months
5 Difficult to discontinue antithrombotic drugs during preoperative period
6 Severe infectious disease needed systemic treatment
7 Patients judged inappropriate by investigator or attending doctor
Target sample size 65

Research contact person
Name of lead principal investigator Toshiyuki Yoshio
Organization Cancer Institute Hospital
Division name Gstroenterology
Address 3-8-31, Ariake, Koto-ku, Tokyo, Japan
TEL 03-3520-0111
Email toshiyuki.yoshio@jfcr.or.jp

Public contact
Name of contact person Toshiyuki Yoshio
Organization Cancer Institute Hospital
Division name Gastroenterology
Address 3-8-31, Ariake, Koto-ku, Tokyo, Japan
TEL 03-3520-0111
Homepage URL
Email toshiyuki.yoshio@jfcr.or.jp

Sponsor
Institute Department of Gastroenterology,Cancer Institute Hospital
Institute
Department

Funding Source
Organization non
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions がん研有明病院(東京都)

Other administrative information
Date of disclosure of the study information
2015 Year 04 Month 28 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 08 Month 18 Day
Anticipated trial start date
2014 Year 10 Month 20 Day
Last follow-up date
2015 Year 10 Month 23 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 04 Month 28 Day
Last modified on
2018 Year 12 Month 21 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020077